Masahide Oki

Nagoya, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 139 publications

A case of malignant lymphoma with a peripheral pulmonary lesion diagnosed by endobronchial ultrasound-guided needle aspiration using a thin convex-probe endobronchial ultrasound bronchoscope.

A case of malignant lymphoma with a peripheral pulmonary lesion diagnosed by endobronchial ultrasound-guided needle aspiration using a thin convex-probe endobronchial ultrasound bronchoscope.

Journal: Respiratory medicine case reports

Published: February 17, 2026

Transbronchial cryobiopsy for peripheral pulmonary lesions using ultrathin bronchoscopy: a narrative review.

Transbronchial cryobiopsy for peripheral pulmonary lesions using ultrathin bronchoscopy: a narrative review.

Journal: Journal of thoracic disease

Published: December 09, 2025

Immune-related gene expression profiling and alectinib efficacy for patients with ALK-Rearranged non-small cell lung cancer: exploratory analysis of a prospective observational study.

Immune-related gene expression profiling and alectinib efficacy for patients with ALK-Rearranged non-small cell lung cancer: exploratory analysis of a prospective observational study.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: November 05, 2025

Does needle size affect the diagnostic yield of endobronchial ultrasound-guided transbronchial needle aspiration for malignant lymphoma?-a narrative review.

Does needle size affect the diagnostic yield of endobronchial ultrasound-guided transbronchial needle aspiration for malignant lymphoma?-a narrative review.

Journal: Mediastinum (Hong Kong, China)

Published: October 25, 2025

EBUS-TBNA for lung cancer in the apical segment of the right upper lobe using a new EBUS scope.

EBUS-TBNA for lung cancer in the apical segment of the right upper lobe using a new EBUS scope.

Journal: Respiratory medicine case reports

Published: October 22, 2025

Daily low-dose carboplatin or weekly carboplatin plus nab-paclitaxel for concurrent chemoradiotherapy in older patients with locally advanced non-small cell lung cancer (JCOG1914): A randomized phase 3 trial.

Daily low-dose carboplatin or weekly carboplatin plus nab-paclitaxel for concurrent chemoradiotherapy in older patients with locally advanced non-small cell lung cancer (JCOG1914): A randomized phase 3 trial.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: October 18, 2025

A Case of Extensive Airway Necrosis Following Esophagectomy Successfully Treated with Airway Stenting.

A Case of Extensive Airway Necrosis Following Esophagectomy Successfully Treated with Airway Stenting.

Journal: Clinics and practice

Published: October 17, 2025

Rigid bronchoscopic intervention for airway stenosis in post-pneumonectomy patients.

Rigid bronchoscopic intervention for airway stenosis in post-pneumonectomy patients.

Journal: BMC pulmonary medicine

Published: September 28, 2025

Aerogenous Dissemination of DEK::AFF2 Carcinoma : A Prototype of a Previously Underrecognized Pattern of Endobronchial Metastasis From Extrathoracic Malignancies.

Aerogenous Dissemination of DEK::AFF2 Carcinoma : A Prototype of a Previously Underrecognized Pattern of Endobronchial Metastasis From Extrathoracic Malignancies.

Journal: The American journal of surgical pathology

Published: August 11, 2025

Amivantamab Plus Chemotherapy in Japanese Patients With EGFR Exon 20 Insertions NSCLC.

Amivantamab Plus Chemotherapy in Japanese Patients With EGFR Exon 20 Insertions NSCLC.

Journal: Cancer science

Published: July 17, 2025

Cemiplimab in Japanese patients with advanced non-small cell lung cancer.

Cemiplimab in Japanese patients with advanced non-small cell lung cancer.

Journal: Japanese journal of clinical oncology

Published: July 11, 2025

Radiotherapy-free pembrolizumab combined with chemotherapy for locally advanced non-small-cell lung cancer with PD-L1 tumour proportion score of 50% or higher (Evolution trial): a multicentre, single-arm, phase 2 study.

Radiotherapy-free pembrolizumab combined with chemotherapy for locally advanced non-small-cell lung cancer with PD-L1 tumour proportion score of 50% or higher (Evolution trial): a multicentre, single-arm, phase 2 study.

Journal: The Lancet. Oncology

Published: April 19, 2025

Showing 1-12 of 139

Last Updated: 09/26/2026